Nakamoto Inc.

Companies

Nakamoto Inc. (formerly Nakamoto Holdings) is a publicly traded Bitcoin-focused holding company founded by David Bailey, CEO of Bitcoin Magazine, formed via reverse merger with KindlyMD in 2025. The company trades on Nasdaq under ticker NAKA and has raised $710 million for Bitcoin accumulation with a stated long-term goal of holding 1 million BTC. In February 2026, Nakamoto Inc. acquired BTC Inc. (publisher of Bitcoin Magazine) and UTXO Management, consolidating key Bitcoin media and investment assets under one publicly traded entity.

Details

Ceo: David Bailey
Public: Yes
Sector: financial_services
Ticker: NAKA
Acquired: BTC Inc.,UTXO Management
Exchange: NASDAQ
Formerly: Nakamoto Holdings
Market Cap: ~$600M (as of Q1 2026)
Founded Year: 2025
Headquarters: USA
Capital Raised: $510M committed (2025)
Bitcoin Holdings: 5398
Bitcoin Strategy: Pure-play Bitcoin treasury vehicle
Btc Holdings Date: 2025-03
Bitcoin Holdings Date: 2025-12

Links

twitter

More Companies

Strategy (formerly MicroStrategy)

Strategy (Nasdaq: MSTR), formerly MicroStrategy, is the world's largest corporate Bitcoin holder. Founded by Michael Saylor, the company rebranded in 2025 to reflect its identity as a Bitcoin treasury company. It holds over 500,000 BTC accumulated through equity and debt financing, pioneering the corporate Bitcoin standard that inspired hundreds of companies worldwide.

ACINQ

ACINQ is a French Bitcoin infrastructure company and the developer of Eclair, one of the three major Lightning Network implementations. Founded in 2014, ACINQ builds Phoenix Wallet (a non-custodial Lightning wallet) and operates the ACINQ Lightning node, one of the most well-connected nodes on the Lightning Network.

Acurx Pharmaceuticals

Acurx Pharmaceuticals (NASDAQ: ACXP) is a US biopharmaceutical company that made headlines in November 2021 by adopting Bitcoin as its primary treasury reserve asset — one of the first pharmaceutical companies to do so. The company approved purchasing $1 million in Bitcoin and has continued to hold BTC alongside its drug development pipeline focused on antibiotics. Notable for crossing industry boundaries to embrace the Bitcoin standard.